FundedIQ
Biotechnology

H1: Funding, Investors & Team (Oct 2026)

H1 provides a global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organizations. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.

www.h1.co LinkedIn New York, United States 251-500 employees
Biotechnology Health Care Life Science Medical Therapeutics
Total raised
$110M
Rounds
2
Latest
Debt Financing
Jun 2022

H1 has raised $110M across 2 funding rounds on record, the most recent a Debt Financing of $10.0M announced in Jun 2022.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

H1 Company Profile and Key Stats

Total funding raised
$110M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Debt Financing
$10.0M in Jun 2022
Employees
251-500
reported band
Headquarters
New York, United States

Latest funding round on record: Jun 2022.

H1 Funding Rounds

Date
Round
Amount
Debt Financing
$10.0M
Series C
$100M

H1 raised $100M in a Series C announced in Nov 2021.

7 months later, a Debt Financing of $10.0M was announced in Jun 2022.

H1 Founders and Leadership Team

Name
Role
Contact
Ian Sax
Founder
Locked
Ariel Katz
CEO
Locked

Contact details for the H1 team: 2 of 2 have an email address on file.

Start 14-day free trial →

H1 Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

H1's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like H1 in Biotechnology and New York

Companies Similar to H1

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

H1 Funding FAQs

What does H1 do?

H1 provides a global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organizations. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.

How much funding has H1 raised?

H1 has raised $110M across 2 rounds on record. The most recent is a Debt Financing of $10.0M announced in Jun 2022.

When did H1 last raise funding?

H1's most recent funding round on record is a Debt Financing of $10.0M, announced in Jun 2022.

Who founded H1?

FundedIQ lists Ian Sax (Founder) at H1.

Who is the CEO of H1?

Ariel Katz is listed as CEO at H1.

Where is H1 headquartered?

H1 is based in New York, United States.

How many employees does H1 have?

H1 is in the 251-500 employee band.

How does H1's funding compare to other Biotechnology startups?

H1's latest round of $10.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's H1 Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for H1 is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.